16 August 2018
Visiongain’s new report Global Ophthalmic Devices Market 2017-2027: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others indicates that the global ophthalmic devices market will see $24.19bn in spending in 2021.
The global ophthalmic devices market is expected to grow at a CAGR of 5.7% in the first half of the forecast period. The market is expected to grow at a CAGR of 6.4% from 2017-2027. The market is estimated at $18.33bn in 2016 and $24.19bn in 2021. In 2016, the surgical devices submarket held the largest market share at 45.9%, followed by the vision care submarket at 41.7%.
The lead analyst of the report said: “ The main drivers of growth in this market will be an ageing global population, higher incidence of diabetes resulting in related ocular problems, rapid growth in the emerging economies and innovative technologies. Current limitations of pharmaceutical treatments, as well of ophthalmic diagnostics and monitoring and surgical devices will continue to drive innovation. Patient compliance and cost effectiveness will be the key factors to be considered in developing new devices”
The 190-page report contains 67 tables and 58 figures that add visual analysis in order to explain the developing trends within the Global Ophthalmic Devices Market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the global ophthalmic devices market and its leading submarkets: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others.
The 190-page report offers market forecasts for the US, Germany, France, The UK, Italy, Spain, Japan, China, Brazil, Russia, India, South Korea and Rest of the World
Moreover, our work discusses the leading companies in the ophthalmic devices market. Our study also discusses Porter’s Five Forces analysis that influence the global ophthalmic devices market
The report Global Ophthalmic Devices Market 2017-2027: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others report will be of value to anyone who wants to better understand the ophthalmic devices market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the ophthalmic devices market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the globe.
30 September 2020
Maintaining the quality and safety of the product in the supply chain has always been a high priority for pharmaceutical companies. New market dynamics including an evolving product line, more stringent regulations, geographically connected supply chains, rising risk, and extreme cost pressure have raised stakes significantly.
28 September 2020
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.